Cardiomyopathy

Clinical Trial Finder

Many patients with cardiomyopathy are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Left Atrial Volume Index in Asymptomatic Aortic Stenosis

Conditions:   Aortic Valve Stenosis;   Heart Failure
Intervention:  
Sponsor:   Odense University Hospital
Recruiting - verified March 2015

Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell Disease

Condition:   Sickle Cell Disease
Interventions:   Other: Cardiac echography;   Other: Biological parameters;   Other: Clinical parameters
Sponsor:   Brugmann University Hospital
Recruiting - verified March 2015

Ciclosporin to Reduce Reperfusion Injury in Primary PCI

Condition:   Myocardial Reperfusion Injury
Interventions:   Drug: Ciclosporin;   Drug: Saline
Sponsors:   Newcastle-upon-Tyne Hospitals NHS Trust;   National Institute for Health Research Newcastle Biomedical Research Centre;   Newcastle University
Not yet recruiting - verified March 2015

End-Of-Life Decision Making and Preparedness Planning Among Heart Failure Patients Hospitalized for Advanced Disease

Condition:   Heart Failure
Intervention:   Other: Decision Making Intervention
Sponsor:   Saint Luke's Health System
Enrolling by invitation - verified March 2015

First in Human Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

Condition:   Hypertrophic Cardiomyopathy
Intervention:   Drug: MYK-461
Sponsor:   MyoKardia, Inc.
Recruiting - verified March 2015

Effect of GS-6615 on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Interventions:   Drug: GS-6615;   Drug: Placebo
Sponsor:   Gilead Sciences
Recruiting - verified March 2015

Budapest Upgrade CRT Study (Version 009-1)

Condition:   Cardiomyopathy
Intervention:   Device: CRT-D
Sponsors:   Bela Merkely;   University of Rochester;   Sheba Medical Center
Enrolling by invitation - verified March 2015

Prospective Becker-Heart-Study

Conditions:   Dilated Cardiomyopathy;   Lef Ventricular Dysfunction;   Heart Failure
Intervention:   Procedure: ECG, echocardiography, cardiac MRI, sera biomarkers
Sponsors:   Karim WAHBI;   Institut de Myologie, France
Recruiting - verified March 2015

Implantable Cardioverter Defibrillator (ICD Registry)

Conditions:   Heart Failure;   Nonischemic Cardiomyopathy;   Ischemic Cardiomyopathy;   Ventricular Arrhythmia;   Complications; Device, Cardiac
Intervention:  
Sponsors:   American College of Cardiology;   The Heart Rhythm Society
Recruiting - verified March 2015

SmartTouch Catheter in Ablation of Ventricular Tachycardia

Conditions:   Arrhythmias, Cardiac;   Tachycardia, Ventricular;   Myocardial Infarction;   Cardiomyopathies
Intervention:  
Sponsors:   Hospital Universitario Virgen de la Arrixaca;   Biosense Webster, Inc.
Active, not recruiting - verified March 2015

A Biomarker and MRI Study on Troponin Release After Exercise in Hypertrophic Cardiomyopathy

Condition:   Hypertrophic Cardiomyopathy
Intervention:  
Sponsor:   Heartcenter, University Medical Center St. Radboud
Recruiting - verified March 2015

Biomarkers in Aortic Stenosis - B.A.S.S.

Conditions:   Aortic Stenosis;   Disorder of Prosthetic Cardiac Valve;   Aortic Valve Insufficiency;   Mitral Valve Insufficiency;   Hypertrophic Cardiomyopathy;   Tricuspid Valve Insufficiency
Interventions:   Procedure: Blood Draw;   Other: Blood draw
Sponsor:   Mayo Clinic
Recruiting - verified March 2015

Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage

Conditions:   Inflammation;   Cancer;   Cardiomyopathy
Intervention:  
Sponsor:   National Institute of Environmental Health Sciences (NIEHS)
Enrolling by invitation - verified December 2014

A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers

Conditions:   Myocardial Infarction;   Myocardial Ischemia
Interventions:   Drug: thymosin beta 4;   Other: Placebo
Sponsor:   RegeneRx Biopharmaceuticals, Inc.
Completed - verified March 2015

Study of Muromonab-CD3 and Cyclosporine in Patients With Giant Cell Myocarditis

Condition:   Myocarditis
Interventions:   Drug: Muromonab-CD3;   Drug: Cyclosporine
Sponsor:   Mayo Clinic
Completed - verified October 2001

Get CardioSmart

You're Invited